Susan H. Blanton < Susan H. Fox < Susan Harris

Facettes :

List of bibliographic references indexed by Susan H. Fox

Number of relevant bibliographic references: 72.
[0-50] [0 - 20][0 - 50][50-70]

Ident.	Authors (with country if any)	Title
000004 (2017)	Susan H. Fox [Canada] ; Leonard Verhagen Metman [États-Unis] ; John G. Nutt [États-Unis] ; Matthew Brodsky [États-Unis] ; Stewart A. Factor [États-Unis] ; Anthony E. Lang [Canada] ; Laura E. Pope [États-Unis] ; Nadine Knowles [États-Unis] ; João Siffert [États-Unis]	Trial of dextromethorphan/quinidine to treat levodopa-induced dyskinesia in Parkinson's disease.
000123 (2017)	Anthony H V. Schapira [Royaume-Uni] ; Susan H. Fox [Canada] ; Robert A. Hauser ; Joseph Jankovic [États-Unis] ; Wolfgang H. Jost [Allemagne] ; Christopher Kenney [États-Unis] ; Jaime Kulisevsky [Espagne] ; Rajesh Pahwa ; Werner Poewe [Autriche] ; Ravi Anand [Suisse]	Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial.
000224 (2016)	Anna Chang [Canada] ; Susan H. Fox [Canada]	Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.
000267 (2016)	Maria Eliza Freitas [Canada] ; Susan H. Fox [Canada]	Nondopaminergic treatments for Parkinson's disease: current and future prospects.
000367 (2016)	Renato P. Munhoz [Canada] ; Marina Picillo [Canada] ; Susan H. Fox [Canada] ; Veronica Bruno [Canada] ; Michel Panisset [Canada] ; Christopher R. Honey [Canada] ; Alfonso Fasano [Canada]	Eligibility Criteria for Deep Brain Stimulation in Parkinson's Disease, Tremor, and Dystonia.
000410 (2016)	Scott A. Norris [États-Unis] ; H A Jinnah [États-Unis] ; Alberto J. Espay [États-Unis] ; Christine Klein [Allemagne] ; Norbert Brüggemann [Allemagne] ; Richard L. Barbano [États-Unis] ; Irene Andonia C. Malaty [États-Unis] ; Ramon L. Rodriguez [États-Unis] ; Marie Vidailhet [France] ; Emmanuel Roze [France] ; Stephen G. Reich [États-Unis] ; Brian D. Berman [États-Unis] ; Mark S. Ledoux [États-Unis] ; Sarah Pirio Richardson [États-Unis] ; Pinky Agarwal [États-Unis] ; Zoltan Mari [États-Unis] ; William G. Ondo [États-Unis] ; Ludy C. Shih [États-Unis] ; Susan H. Fox [Canada] ; Alfredo Berardelli [Italie] ; Claudia M. Testa [États-Unis] ; Florence Ching-Fen Cheng [Australie] ; Daniel Truong [États-Unis] ; Fatta B. Nahab [États-Unis] ; Tao Xie [États-Unis] ; Mark Hallett [États-Unis] ; Ami R. Rosen [États-Unis] ; Laura J. Wright [États-Unis] ; Joel S. Perlmutter [États-Unis]	Clinical and demographic characteristics related to onset site and spread of cervical dystonia.
000427 (2016)	Veronica A. Bruno [Canada] ; Susan H. Fox [Canada] ; Deborah Mancini [Canada] ; Janis M. Miyasaki [Canada]	Botulinum Toxin Use in Refractory Pain and Other Symptoms in Parkinsonism.
000474 (2015)	Tiago A. Mestre [Canada] ; Isabelle Beaulieu-Boire [Canada] ; Camila C. Aquino [Canada] ; Nicolas Phielipp [États-Unis] ; Yu Yan Poon [Canada] ; Jane P. Lui [Canada] ; Julie So [Canada] ; Susan H. Fox [Canada]	What is a clinically important change in the Unified Dyskinesia Rating Scale in Parkinson's disease?
000522 (2015)	Tom M. Johnston [Canada] ; Susan H. Fox	Symptomatic Models of Parkinson's Disease and L-DOPA-Induced Dyskinesia in Non-human Primates.
000551 (2015)	Yilong Ma [États-Unis] ; Tom H. Johnston [Canada] ; Shichun Peng [États-Unis] ; Chuantao Zuo [République populaire de Chine] ; James B. Koprich [Canada] ; Susan H. Fox [Canada] ; Yihui Guan [République populaire de Chine] ; David Eidelberg [États-Unis] ; Jonathan M. Brotchie [Canada]	Reproducibility of a Parkinsonism-related metabolic brain network in non-human primates: A descriptive pilot study with FDG PET.
000582 (2015)	Kaviraja Udupa [Canada] ; Susan H. Fox [Canada]	Placebo effect in Parkinson's disease: Harnessing the mind in the treatment of PD.
000641 (2015)	Philippe Huot [Canada] ; Susan H. Fox [Canada] ; Jonathan M. Brotchie [Canada]	Monoamine Reuptake Inhibitors in Parkinson's Disease
000701 (2015)	Ai Huey Tan [Malaisie] ; Sanjiv Mahadeva [Malaisie] ; Connie Marras [Canada] ; Abdul Malik Thalha [Malaisie] ; Chiun Khang Kiew [Malaisie] ; Chia Ming Yeat [Malaisie] ; Sheang Wen Ng [Malaisie] ; Sheau Phing Ang [Malaisie] ; Siew Kian Chow [Malaisie] ; Mun Fai Loke [Malaisie] ; Jamunarani S. Vadivelu [Malaisie] ; Norlinah Ibrahim [Malaisie] ; Hoi Sen Yong [Malaisie] ; Chong Tin Tan [Malaisie] ; Susan H. Fox [Canada] ; Anthony E. Lang [Canada] ; Shen-Yang Lim [Malaisie]	Helicobacter pylori infection is associated with worse severity of Parkinson's disease.
000770 (2015)	Cynthia L. Comella [États-Unis] ; Susan H. Fox [Canada] ; Kailash P. Bhatia [Royaume-Uni] ; Joel S. Perlmutter [États-Unis] ; Hyder A. Jinnah [États-Unis] ; Mateusz Zurowski [Canada] ; William M. Mcdonald [États-Unis] ; Laura Marsh [États-Unis] ; Ami R. Rosen [États-Unis] ; Tracy Waliczek [États-Unis] ; Laura J. Wright [États-Unis] ; Wendy R. Galpern [États-Unis] ; Glenn T. Stebbins [États-Unis]	Development of the Comprehensive Cervical Dystonia Rating Scale: Methodology
000794 (2015)	Camila Catherine Aquino [Canada] ; Susan H. Fox	Clinical spectrum of levodopa-induced complications.
000873 (2014)	Camila C. Aquino [Canada] ; Susan H. Fox	Understanding conversion disorders: back to Freud's theory.
000877 (2014)	Philippe Huot [Canada] ; Tom H. Johnston [Canada] ; Katie D. Lewis [Australie] ; James B. Koprich [Canada] ; M Gabriela Reyes [Canada] ; Susan H. Fox [Canada] ; Matthew J. Piggott [Australie] ; Jonathan M. Brotchie [Canada]	UWA-121, a mixed dopamine and serotonin re-uptake inhibitor, enhances L-DOPA anti-parkinsonian action without worsening dyskinesia or psychosis-like behaviours in the MPTP-lesioned common marmoset.
000927 (2014)	Ai Huey Tan [Malaisie] ; Sanjiv Mahadeva [Malaisie] ; Abdul Malik Thalha [Malaisie] ; Peter R. Gibson [Australie] ; Chiun Khang Kiew [Malaisie] ; Chia Ming Yeat [Malaisie] ; Sheang Wen Ng [Malaisie] ; Sheau Phing Ang [Malaisie] ; Siew Kian Chow [Malaisie] ; Chong Tin Tan [Malaisie] ; Hoi Sen Yong [Malaisie] ; Connie Marras [Canada] ; Susan H. Fox [Canada] ; Shen-Yang Lim [Malaisie]	Small intestinal bacterial overgrowth in Parkinson's disease.
000971 (2014)	Susan H. Fox [Canada]	Pimavanserin as treatment for Parkinson's disease psychosis.
000A70 (2014)	Amaal Al Dakheel [Canada] ; Isabelle Beaulieu-Boire ; Susan H. Fox	Emerging drugs for levodopa-induced dyskinesia.
000B77 (2014)	Susan H. Fox [Canada] ; Anthony E. Lang [Canada]	'Don't delay, start today': delaying levodopa does not delay motor complications.
000C31 (2013)	Barbara Connolly [Canada] ; Susan H. Fox [Canada]	Treatment of Cognitive, Psychiatric, and Affective Disorders Associated with Parkinson’s Disease
000C38 (2013)	Philippe Huot [Canada] ; Susan H. Fox	The serotonergic system in motor and non-motor manifestations of Parkinson's disease.
000C43 (2013)	Philippe Huot [Canada] ; Tom H. Johnston ; James B. Koprich ; Susan H. Fox ; Jonathan M. Brotchie	The pharmacology of L-DOPA-induced dyskinesia in Parkinson's disease.
000C50 (2013)	James B. Koprich [Canada] ; Philippe Huot ; Susan H. Fox ; Keith Jarvie ; Anthony E. Lang ; Philip Seeman ; Jonathan M. Brotchie	The effects of fast-off-D2 receptor antagonism on L-DOPA-induced dyskinesia and psychosis in parkinsonian macaques.
000D19 (2013)	Susan H. Fox [Canada]	Non-dopaminergic treatments for motor control in Parkinson's disease.
000E81 (2013)	Tiago A. Mestre [Canada] ; Mateusz Zurowski ; Susan H. Fox	5-Hydroxytryptamine 2A receptor antagonists as potential treatment for psychiatric disorders.
000E88 (2013)	Lorraine V. Kalia [Canada] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada]	Novel nondopaminergic targets for motor features of Parkinson's disease: Review of recent trials
000F09 (2013)	Philippe Huot [Canada] ; Tom H. Johnston [Canada] ; Tessa Snoeren [Pays-Bas] ; James B. Koprich [Canada] ; Michael P. Hill [Canada] ; Susan H. Fox [Canada] ; Jonathan M. Brotchie [Canada]	Use of catechol‐O‐methyltransferase inhibition to minimize L‐3,4‐dihydroxyphenylalanine‐induced dyskinesia in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐lesioned macaque
001036 (2013)	Philippe Huot [Canada] ; Susan H. Fox [Canada]	The serotonergic system in motor and non-motor manifestations of Parkinson's disease
001038 (2013)	James B. Koprich [Canada] ; Philippe Huot [Canada] ; Susan H. Fox [Canada] ; Keith Jarvie [Canada] ; Anthony E. Lang [Canada] ; Philip Seeman [Canada] ; Jonathan M. Brotchie [Canada]	The effects of fast-off-D2 receptor antagonism on L-DOPA-induced dyskinesia and psychosis in parkinsonian macaques
001057 (2013)	Susan H. Fox [Canada]	Non-dopaminergic Treatments for Motor Control in Parkinson's Disease
001116 (2012)	Philippe Huot [Canada] ; Tom H. Johnston [Canada] ; Michael N. Gandy [Australie] ; M. Gabriela Reyes [Canada] ; Susan H. Fox [Canada] ; Matthew J. Piggott [Australie] ; Jonathan M. Brotchie [Canada]	The Monoamine Re-Uptake Inhibitor UWA-101 Improves Motor Fluctuations in the MPTP-Lesioned Common Marmoset
001191 (2012)	Philippe Huot [Canada] ; Tom H. Johnston ; James B. Koprich ; Ahmed Aman ; Susan H. Fox ; Jonathan M. Brotchie	L-745,870 reduces L-DOPA-induced dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease.
001249 (2012)	Barbara S. Connolly [Canada] ; Susan H. Fox	Drug treatments for the neuropsychiatric complications of Parkinson's disease.
001293 (2012)	Tom H. Johnston [Canada] ; Zak Millar ; Philippe Huot ; Keith Wagg ; Sherri Thiele ; Danielle Salomonczyk ; Christopher J. Yong-Kee ; Michael N. Gandy ; Matthew Mcildowie ; Katie D. Lewis ; Jordi Gomez-Ramirez ; Joohyung Lee ; Susan H. Fox ; Mathew Martin-Iverson ; Joanne E. Nash ; Matthew J. Piggott ; Jonathan M. Brotchie	A novel MDMA analogue, UWA-101, that lacks psychoactivity and cytotoxicity, enhances L-DOPA benefit in parkinsonian primates.
001413 (2012)	Philippe Huot [Canada] ; Tom H. Johnston [Canada] ; Naomi P. Visanji [Canada] ; Tayyeba Darr [Canada] ; Donna Pires [Canada] ; Lili-Naz Hazrati [Canada] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada]	Increased levels of 5‐HT1A receptor binding in ventral visual pathways in Parkinson's disease
001477 (2012)	Susan H. Fox [Canada] ; Tom H. Johnston [Canada] ; Qin Li [République populaire de Chine] ; Jonathan Brotchie [Canada] ; Erwan Bezard [République populaire de Chine, France]	A critique of available scales and presentation of the non‐human primate dyskinesia rating scale
001574 (2011)	Philippe Huot [Canada] ; Susan H. Fox ; Jonathan M. Brotchie	The serotonergic system in Parkinson's disease.
001723 (2011)	Philippe Huot [Canada] ; Susan H. Fox ; Adrian Newman-Tancredi ; Jonathan M. Brotchie	Anatomically selective serotonergic type 1A and serotonergic type 2A therapies for Parkinson's disease: an approach to reducing dyskinesia without exacerbating parkinsonism?
001778 (2011)	James B. Koprich [Canada] ; Susan H. Fox [Canada] ; Tom H. Johnston [Canada] ; Allan Goodman [États-Unis] ; Bertrand Le Bourdonnec [États-Unis] ; Roland E. Dolle [États-Unis] ; Robert N. Dehaven [États-Unis] ; Diane L. Dehaven-Hudkins [États-Unis] ; Patrick J. Little [États-Unis] ; Jonathan M. Brotchie [Canada]	The selective mu‐opioid receptor antagonist adl5510 reduces levodopa‐induced dyskinesia without affecting antiparkinsonian action in mptp‐lesioned macaque model of Parkinson's disease
001786 (2011)	Klaus Seppi [Autriche, Portugal] ; Daniel Weintraub [États-Unis] ; Miguel Coelho [Portugal] ; Santiago Perez-Lloret [France] ; Susan H. Fox [Canada] ; Regina Katzenschlager [Autriche] ; Eva-Maria Hametner [Autriche] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Christopher G. Goetz [États-Unis] ; Cristina Sampaio [Portugal]	The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease
001787 (2011)	Susan H. Fox [Canada] ; Regina Katzenschlager [Autriche] ; Shen-Yang Lim [Malaisie] ; Bernard Ravina [États-Unis] ; Klaus Seppi [Autriche] ; Miguel Coelho [Portugal] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Christopher G. Goetz [États-Unis] ; Cristina Sampaio [Portugal]	The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease
001824 (2011)	Arpan R. Mehta [Canada, Royaume-Uni] ; Susan H. Fox [Canada] ; Mark Tarnopolsky [Canada] ; Grace Yoon [Canada]	Mitochondrial mimicry of multiple system atrophy of the cerebellar subtype
001986 (2010)	Susan H. Fox [Canada] ; Jonathan M. Brotchie	The MPTP-lesioned non-human primate models of Parkinson's disease. Past, present, and future.
001993 (2010)	Benedicte Ballanger [Canada] ; Antonio P. Strafella ; Thilo Van Eimeren ; Mateusz Zurowski ; Pablo M. Rusjan ; Sylvain Houle ; Susan H. Fox	Serotonin 2A receptors and visual hallucinations in Parkinson disease.
001996 (2010)	Tom H. Johnston [Canada] ; Susan H. Fox ; Matthew J. Mcildowie ; Matthew J. Piggott ; Jonathan M. Brotchie	Reduction of L-DOPA-induced dyskinesia by the selective metabotropic glutamate receptor 5 antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease.
001B23 (2010)	Pettarusp M. Wadia [Canada] ; Gamaliel Tan [Canada] ; Renato P. Munhoz [Canada] ; Susan H. Fox [Canada] ; Stephen J. Lewis [Canada] ; Anthony E. Lang [Canada]	Surgical correction of kyphosis in patients with camptocormia due to Parkinson's disease: a retrospective evaluation
001B51 (2010)	Tom H. Johnston [Canada] ; Susan H. Fox [Canada] ; Matthew J. Piggott [Australie] ; Juha-Matti Savola [Suisse] ; Jonathan M. Brotchie [Canada]	The α2 adrenergic antagonist fipamezole improves quality of levodopa action in Parkinsonian primates
001C09 (2010)	Philippe Huot [Canada] ; Tom H. Johnston [Canada] ; Tayyeba Darr [Canada] ; Lili-Naz Hazrati [Canada] ; Naomi P. Visanji [Canada] ; Donna Pires [Canada] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada]	Increased 5‐HT2A receptors in the temporal cortex of parkinsonian patients with visual hallucinations
001C36 (2010)	Tom H. Johnston [Canada] ; Anne Van Der Meij [Pays-Bas] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada]	Effect of histamine H2 receptor antagonism on levodopa–induced dyskinesia in the MPTP‐macaque model of Parkinson's disease

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i -k "Susan H. Fox" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i  \
                -Sk "Susan H. Fox" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Author.i
   |clé=    Susan H. Fox
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022